Sigilon Therapeutics Inc.

NASDAQ: SGTX · Real-Time Price · USD
22.47
-0.59 (-2.56%)
At close: Aug 10, 2023, 8:00 PM

Sigilon Therapeutics Statistics

Share Statistics

Sigilon Therapeutics has 2.5M shares outstanding. The number of shares has increased by 2.94% in one year.

2.5M
2.94%
0.18%
n/a
n/a
27
0.02%

Short Selling Information

The latest short interest is 8.23K, so 0.33% of the outstanding shares have been sold short.

8.23K
0.33%
0.48%
1

Valuation Ratios

The PE ratio is -3.39 and the forward PE ratio is null. Sigilon Therapeutics's PEG ratio is 0.04.

-3.39
n/a
11.39
n/a
3.77
-2.83
0.04
Financial Ratio History

Enterprise Valuation

Sigilon Therapeutics has an Enterprise Value (EV) of 133.44M.

10.31
-3.23
-2.59
-2.57

Financial Position

The company has a current ratio of 2.4, with a Debt / Equity ratio of 0.72.

2.4
2.39
0.72
-0.68
-0.54
-19.07

Financial Efficiency

Return on Equity is -111.02% and Return on Invested Capital is -64.82%.

-111.02%
-49.79%
-64.82%
$208,774.19
$-700,903.23
62
0.15
n/a

Taxes

-105K
0.24%

Stock Price Statistics

The stock price has increased by 0% in the last 52 weeks. The beta is 4.11, so Sigilon Therapeutics's price volatility has been higher than the market average.

4.11
n/a
16.97
10.29
71.26
120,683

Income Statement

In the last 12 months, Sigilon Therapeutics had revenue of 12.94M and earned -43.46M in profits. Earnings per share was -1.34.

12.94M
12.94M
-43.67M
-43.46M
-41.27M
-41.27M
-1.34
Full Income Statement

Balance Sheet

The company has 42.07M in cash and 28.06M in debt, giving a net cash position of 14.01M.

42.07M
28.06M
14.01M
-256.8M
55.56M
19.62M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -51.47M and capital expenditures -537K, giving a free cash flow of -52.01M.

-51.47M
-537K
-52.01M
-1.6
Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of -337.35% and -335.72%.

100%
-337.35%
-336.53%
-335.72%
-318.84%
-337.35%
-401.82%

Dividends & Yields

SGTX does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
-29.47%
-35.27%
Dividend Details

Analyst Forecast

Currently there are no analyst rating for SGTX.

n/a
n/a
n/a
n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on May 23, 2023. It was a backward split with a ratio of 1:13.

May 23, 2023
backward
1:13

Scores

-6.71
3